{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:22:05Z","timestamp":1788988925793,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jaci.2024.01.025","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T05:11:35Z","timestamp":1710997895000},"page":"1711-1720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Autoimmune adverse event following COVID-19 vaccination in Seoul, South Korea"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8162-9585","authenticated-orcid":false,"given":"Hong Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong Geun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-2722","authenticated-orcid":false,"given":"Eun Mi","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2024.01.025_bib1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2024.01.025_bib2","article-title":"Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks","volume":"53","author":"Wang","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaci.2024.01.025_bib3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2024.01.025_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2024.01.025_bib5","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"27","author":"Patone","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2024.01.025_bib6","first-page":"1","article-title":"A review of adverse effects of COVID-19 vaccines","volume":"30","author":"Mushtaq","year":"2022","journal-title":"Infez Med"},{"key":"10.1016\/j.jaci.2024.01.025_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijid.2022.03.007","article-title":"Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: a nationwide observational study","volume":"118","author":"Lee","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jaci.2024.01.025_bib8","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/exd.14407","article-title":"Does autoimmune vitiligo protect against COVID-19 disease?","volume":"30","author":"Post","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2024.01.025_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2024.01.025_bib10","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/eurheartj\/ehad339","article-title":"COVID-19 vaccination-related myocarditis: a Korean nationwide study","volume":"44","author":"Cho","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaci.2024.01.025_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/ene.15602","article-title":"Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a follow-up study","volume":"30","author":"Doubrovinskaia","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jaci.2024.01.025_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdcr.2022.01.030","article-title":"Vitiligo following COVID-19: a case report and review of pathophysiology","volume":"22","author":"Schmidt","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaci.2024.01.025_bib13","first-page":"1505","article-title":"Risk of COVID-19 related complications in vitiligo patients: a database study","volume":"20","author":"Raiker","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaci.2024.01.025_bib14","article-title":"Vitiligo possibly triggered by COVID-19 vaccination","volume":"14","author":"Militello","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jaci.2024.01.025_bib15","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","article-title":"New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality","volume":"57","author":"Sundararajan","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaci.2024.01.025_bib16","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaci.2024.01.025_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaci.2024.01.025_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax9198","article-title":"A genome-wide transcriptomic analysis of protein-coding genes in human blood cells","volume":"366","author":"Uhlen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jaci.2024.01.025_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.01.025_bib20","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0140-6736(21)02717-3","article-title":"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial","volume":"398","author":"Munro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.01.025_bib21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamadermatol.2023.2162","article-title":"Incidence and prevalence of diagnosed vitiligo according to race and ethnicity, age, and sex in the US","volume":"159","author":"Mastacouris","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2024.01.025_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/pcmr.12949","article-title":"An update on vitiligo pathogenesis","volume":"34","author":"Seneschal","year":"2021","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaci.2024.01.025_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/ced.14842","article-title":"Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?","volume":"47","author":"Aktas","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2024.01.025_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.4865","article-title":"New-onset vitiligo following mRNA-1273 (Moderna) COVID-19 vaccination","volume":"9","author":"Kaminetsky","year":"2021","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.jaci.2024.01.025_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15434","article-title":"Vitiligo worsened following\u00a0the second dose of mRNA SARS-CoV-2 vaccine","volume":"35","author":"Caroppo","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2024.01.025_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15196","article-title":"Sudden onset of vitiligo after COVID-19 vaccine","volume":"35","author":"Ciccarese","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2024.01.025_bib27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Li","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2024.01.025_bib28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2024.01.025_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/gm199","article-title":"The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma","volume":"2","author":"Spritz","year":"2010","journal-title":"Genome Med"},{"key":"10.1016\/j.jaci.2024.01.025_bib30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/pcmr.13101","article-title":"Trained immunity in the pathogenesis of vitiligo","volume":"36","author":"Post","year":"2023","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaci.2024.01.025_bib31","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/jocd.15550","article-title":"Various aspects of the relationship between vitiligo and the COVID-19 pandemic or SARS-CoV-2 vaccines: clinical pearls for dermatologists","volume":"22","author":"Aryanian","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaci.2024.01.025_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00262-008-0506-5","article-title":"Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patients","volume":"58","author":"Jacobs","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaci.2024.01.025_bib33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.122.061025","article-title":"Circulating spike protein detected in post\u2013COVID-19 mRNA vaccine myocarditis","volume":"147","author":"Yonker","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jaci.2024.01.025_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nri.2016.116","article-title":"Dendritic cell migration in health and disease","volume":"17","author":"Worbs","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2024.01.025_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","article-title":"Dendritic cell subsets in T cell programming: location dictates function","volume":"19","author":"Eisenbarth","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2024.01.025_bib36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nri3727","article-title":"Dendritic cell-targeted vaccines\u2014hope or hype?","volume":"14","author":"Kastenm\u00fcller","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2024.01.025_bib37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41421-022-00480-5","article-title":"Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profiling","volume":"8","author":"Ai","year":"2022","journal-title":"Cell Discov"},{"key":"10.1016\/j.jaci.2024.01.025_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2024.01.025_bib39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(22)00094-0","article-title":"Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study","volume":"399","author":"Costa Clemens","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.01.025_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104473","article-title":"Heterologous ChAdOx1-BNT162b2 vaccination in Korean cohort induces robust immune and antibody responses that includes Omicron","volume":"25","author":"Lee","year":"2022","journal-title":"iScience"}],"updated-by":[{"DOI":"10.1016\/j.jaci.2025.01.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000}}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924001295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924001295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T16:57:40Z","timestamp":1736182660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674924001295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0091674924001295"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.01.025","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune adverse event following COVID-19 vaccination in Seoul, South Korea","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}